OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators
Jinho Seo, Young Woo Nam, Seongmi Kim, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 6, pp. 1007-1017
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
Xing Niu, Lijie Chen, Yan Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 273-285
Closed Access | Times Cited: 175

Diversity and complexity of cell death: a historical review
Mi-Ju Park, Shibo Wei, Bosung Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 8, pp. 1573-1594
Open Access | Times Cited: 146

Regulated cell death in myocardial ischemia–reperfusion injury
Q. Xiang, Xin Yi, Xue‐Hai Zhu, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 3, pp. 219-234
Closed Access | Times Cited: 128

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease
Thanh Tùng Nguyễn, Shibo Wei, Ha Nguyen Thi Thu, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 8, pp. 1595-1619
Open Access | Times Cited: 118

Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Peng Zhu, Zhuo-Ran Ke, Jing-Xian Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 101

Roles of RIPK3 in necroptosis, cell signaling, and disease
Michael J. Morgan, You‐Sun Kim
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1695-1704
Open Access | Times Cited: 98

The double-edged functions of necroptosis
Keng Ye, Zhimin Chen, Yanfang Xu
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 83

DAMPs and DAMP-sensing receptors in inflammation and diseases
Ming Ma, Wei Jiang, Rongbin Zhou
Immunity (2024) Vol. 57, Iss. 4, pp. 752-771
Open Access | Times Cited: 68

Eosinophils from A to Z
Lea Gigon, Timothée Fettrelet, Shída Yousefi, et al.
Allergy (2023) Vol. 78, Iss. 7, pp. 1810-1846
Open Access | Times Cited: 52

RIPK3 signaling and its role in regulated cell death and diseases
Yaqi Zhou, Yaxuan Xiang, S. Liu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 16

Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
Y. Cong, Na Li, Zixin Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 4

CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway
Longchen Yu, Qining Guo, Yaping Li, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 2

Keratinocyte death by ferroptosis initiates skin inflammation after UVB exposure
Kavita Vats, Oleg Kruglov, Alicia Mizes, et al.
Redox Biology (2021) Vol. 47, pp. 102143-102143
Open Access | Times Cited: 95

Viral-mediated activation and inhibition of programmed cell death
Shayla Grace Verburg, Rebecca Margaret Lelievre, Michael J. Westerveld, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010718-e1010718
Open Access | Times Cited: 55

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Ibone Labiano, Aloña Agirre‐Lizaso, Paula Olaizola, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 991-1004
Open Access | Times Cited: 46

Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?
Adrianna Gielecińska, Mateusz Kciuk, Esam Bashir Yahya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189024-189024
Open Access | Times Cited: 35

Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
Fuli Shi, Li-sha Yuan, Tak-sui Wong, et al.
Pharmacological Research (2023) Vol. 189, pp. 106697-106697
Open Access | Times Cited: 23

The Molecular Mechanisms of Neuroinflammation in Alzheimer’s Disease, the Consequence of Neural Cell Death
Su-Bin Choi, Sehee Kwon, Jihye Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11757-11757
Open Access | Times Cited: 22

Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics
Mohammad Islamuddin, Xuebin Qin
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15

Entosis: the core mechanism and crosstalk with other cell death programs
Sung-Hoon Kim, Donghyuk Lee, Sung Eun Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 4, pp. 870-876
Open Access | Times Cited: 13

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
Xiaojie Zhang, Bufu Tang, Jinhua Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10

Programmed cell death in tumor immunity: mechanistic insights and clinical implications
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9

LUBAC-mediated M1 Ub regulates necroptosis by segregating the cellular distribution of active MLKL
Nadine Weinelt, Kaja Nicole Wächtershäuser, Gulustan Celik, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top